Stock Analysis, Dividends, Split History

TPH / Tri Pointe Homes, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price13.93
Volume2,021,900.00
Market Cap ($M)2,166.54
Enterprise Value ($M)1,843.61
Book Value ($M)2,031.70
Book Value / Share13.36
Price / Book1.07
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 151,212,457
Common Stock Shares Outstanding 151,162,999
Preferred Stock Shares Outstanding 0
Scoring Models
Piotroski F-Score6.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.06
Return on Assets (ROA)0.05
Return on Equity (ROE)0.10
Balance Sheet (mrq) ($M)
Assets3,872.68
Liabilities1,840.38
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Revenues2,810,272,000.00
Other Real Estate Revenue2,333,000.00
Home Building Revenue2,732,299,000.00
Real Estate Revenue Net2,808,901,000.00
Financial Services Revenue1,371,000.00
Operating Income343.63
Net Income187.55
Earnings Per Share Diluted1.21
Earnings Per Share Basic1.21
Cash Flow Statement (mra) ($M)
Cash From Operations101.67
Cash from Investing-3.58
Cash from Financing-3.58
Identifiers and Descriptors
CUSIP87265H109
Central Index Key (CIK)1561680
Related CUSIPS
87265H959 87265H909

Split History

Stock splits are used by Tri Pointe Homes, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

TRI Pointe's (TPH) CEO Doug Bauer on Q2 2018 Results - Earnings Call Transcript

2018-07-27 seekingalpha
TRI Pointe Group, Inc. (NYSE:TPH) Q2 2018 Earnings Conference Call July 27, 2018 10:00 AM ET (4-0)

Moog (MOG.A) Surpasses Q3 Earnings and Revenue Estimates

2018-07-27 zacks
Moog (MOG.A - Free Report) just came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items. (1-0)

HopFed Bancorp (HFBC) Q2 Earnings and Revenues Top Estimates

2018-07-27 zacks
HopFed Bancorp (HFBC - Free Report) just came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. (5-0)

Is the Options Market Predicting a Spike in Synergy Pharmaceuticals (SGYP) Stock?

2018-07-27 zacks
Investors in Synergy Pharmaceuticals Inc. (SGYP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 19, 2018 $1 Put had some of the highest implied volatility of all equity options today. (1-3)

New Strong Sell Stocks for July 27th

2018-07-27 zacks
Aptose Biosciences Inc. (APTO - Free Report) is the owner and operator of a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 22.2% downward over the last 60 days. (10-1)

Silicon Investor Message Boards

This table lists all message boards related to TPH / Tri Pointe Homes, Inc. on message board site Silicon Investor.

Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets TTPH, Tetraphase Pharmaceuticals TTPH, Tetraphase Pharmaceuticals TTPH, Tetraphase Pharmaceuticals
Mi-Pay (MPAY) 5.5 Billion smartphone devices in use by 2019 Mi-Pay (MPAY) 5.5 Billion smartphone devices in use by 2019 Mi-Pay (MPAY) 5.5 Billion smartphone devices in use by 2019 Smartphones: Symbian, Microsoft, RIM, Apple, and Others Smartphones: Symbian, Microsoft, RIM, Apple, and Others Smartphones: Symbian, Microsoft, RIM, Apple, and Others
Xiaomi Technology: Smartphones, Devices and Services ... Xiaomi Technology: Smartphones, Devices and Services ... Xiaomi Technology: Smartphones, Devices and Services ... Street Photography (streetphoto) Refuge Street Photography (streetphoto) Refuge Street Photography (streetphoto) Refuge
CUSIP: 87265H109